Meeta Peer, MD
Physical Medicine & Rehabilitation · Philadelphia, PANPI 1154328136
Payments from drug & device makers
Across 21 payments — averaging $25.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$207
- Collegium Pharmaceutical, Inc.$69
- Hikma Pharmaceuticals USA$54
- Forte Bio-pharma LLC$49
- Biodelivery Sciences International, Inc.$28
- Pfizer$22
- plus $100 from 6 others
What the payments were for
- Food & beverage$50996%
- Education$214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $207 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Hikma Pharmaceuticals USA | 3 | $54 |
| Forte Bio-pharma LLC | 2 | $49 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Pfizer | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $12 |
How this compares
$530 in reported general payments places this provider in the 70th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 19 | $13,249 |
| Naloxone Hcl | 133 | $9,483 |
| Oxycodone Hcl | 633 | $8,605 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 413 | $4,740 |
| Diclofenac Sodium | 219 | $3,920 |
| EndocetOxycodone Hcl/Acetaminophen | 336 | $3,728 |
| Lidocaine | 72 | $2,522 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $1,363 |
| Gabapentin | 216 | $1,311 |
| Methadone Hcl | 32 | $1,075 |
| Celecoxib | 19 | $592 |
| Tizanidine Hcl | 12 | $350 |
| Omeprazole | 22 | $271 |
| Zolpidem Tartrate | 39 | $192 |
| Baclofen | 15 | $153 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Philadelphia
- Cameron OlezenePhiladelphia$4.1M
- Alberto EsquenaziPhiladelphia$465K
- Kimberly HeckertPhiladelphia$119K
- Elaine HatchPhiladelphia$25K
- Benjamin AbramoffPhiladelphia$15K
- Ramesh GuptaPhiladelphia$14K
- Marisa MoretaPhiladelphia$13K
- M Quinn TatePhiladelphia$6K
- Benjamin KaplanPhiladelphia$5K
- Jeffery RoweKing Of Prussia$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.